Huron Consulting Group Inc. (NASDAQ:HURN) is Leeward Investments LLC MA's 7th Largest Position

Leeward Investments LLC MA trimmed its position in shares of Huron Consulting Group Inc. (NASDAQ:HURN - Free Report) by 4.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 197,220 shares of the business services provider's stock after selling 9,216 shares during the period. Huron Consulting Group comprises 1.5% of Leeward Investments LLC MA's portfolio, making the stock its 7th largest position. Leeward Investments LLC MA owned 1.10% of Huron Consulting Group worth $28,291,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Sowell Financial Services LLC bought a new position in Huron Consulting Group in the first quarter worth about $203,000. Lisanti Capital Growth LLC bought a new position in Huron Consulting Group in the first quarter worth about $4,626,000. Millennium Management LLC grew its holdings in Huron Consulting Group by 58.7% in the fourth quarter. Millennium Management LLC now owns 92,872 shares of the business services provider's stock worth $11,540,000 after purchasing an additional 34,353 shares during the period. Advisor Resource Council purchased a new stake in Huron Consulting Group in the first quarter worth about $986,000. Finally, Asset Management One Co. Ltd. grew its holdings in Huron Consulting Group by 5.7% in the first quarter. Asset Management One Co. Ltd. now owns 59,140 shares of the business services provider's stock worth $8,484,000 after purchasing an additional 3,209 shares during the period. 93.90% of the stock is owned by institutional investors.

Huron Consulting Group Stock Up 0.9%

Shares of NASDAQ:HURN traded up $1.29 during trading on Friday, reaching $139.68. 87,922 shares of the stock traded hands, compared to its average volume of 155,455. The stock has a 50-day moving average of $142.36 and a two-hundred day moving average of $137.00. Huron Consulting Group Inc. has a 52-week low of $96.45 and a 52-week high of $155.00. The company has a debt-to-equity ratio of 1.14, a quick ratio of 2.08 and a current ratio of 2.08. The stock has a market cap of $2.41 billion, a P/E ratio of 20.94 and a beta of 0.28.

Huron Consulting Group (NASDAQ:HURN - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The business services provider reported $1.68 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.52. The firm had revenue of $404.14 million for the quarter, compared to analysts' expectations of $389.27 million. Huron Consulting Group had a net margin of 7.88% and a return on equity of 24.68%. The business's revenue for the quarter was up 11.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.23 earnings per share. As a group, sell-side analysts expect that Huron Consulting Group Inc. will post 6.1 earnings per share for the current fiscal year.

Insider Activity at Huron Consulting Group

In related news, Director H Eugene Lockhart sold 1,040 shares of the stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $136.74, for a total transaction of $142,209.60. Following the transaction, the director owned 8,162 shares in the company, valued at $1,116,071.88. This represents a 11.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John Mccartney sold 500 shares of the stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $136.74, for a total transaction of $68,370.00. Following the completion of the transaction, the director owned 51,817 shares in the company, valued at $7,085,456.58. The trade was a 0.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 2,708 shares of company stock worth $377,421 over the last quarter. Company insiders own 2.15% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on HURN. Benchmark restated a "buy" rating and issued a $165.00 price objective on shares of Huron Consulting Group in a report on Wednesday, March 26th. Wall Street Zen cut shares of Huron Consulting Group from a "buy" rating to a "hold" rating in a report on Friday, May 2nd. Wedbush upped their price objective on shares of Huron Consulting Group from $150.00 to $165.00 and gave the stock an "outperform" rating in a report on Wednesday, March 26th. Barrington Research upped their price objective on shares of Huron Consulting Group from $167.00 to $173.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Finally, William Blair restated an "outperform" rating on shares of Huron Consulting Group in a report on Wednesday, March 26th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $170.75.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.